The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, ...

Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...

Conventional vaccine adjuvants primarily rely on molecular binding and biochemical stimulation to activate immune responses, ...

Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...